CancerPath Insights
Platform Activity — Real-time engagement and public health impact
See how CancerPath is making a difference — tracking awareness, screening engagement, and community reach across the UK and beyond.
Visitor Growth
Total website visitors over time
Platform Activity
Live engagement from around the world
User explored Breast Cancer information
Visitor searched screening services
New visitor from London
Community story viewed
User started symptom checker
Returning visitor accessed CancerPath
User explored Prostate Cancer information
Visitor searched for bowel screening
No personal data is collected or displayed. Activity is anonymised and generalised.
Insights & Recommendations
Auto-generated summaries from live platform engagement data
Key Insights
Platform engagement data is being collected. Insights will appear here as users interact with CancerPath.
Recommended Actions
No specific recommendations yet — insights will appear as engagement data accumulates
Geographic Insights
Cancer screening coverage by local authority
Loading public health data…
Countries Accessed
Where CancerPath visitors are coming from
Most Viewed Cancer Types
Top cancer information pages by views
Most Used Features
Platform features by usage count
About this data
This dashboard displays anonymised, aggregated engagement metrics. No personally identifiable information is collected or shown. Data is currently populated with clearly marked demo figures and will automatically switch to live analytics once platform tracking is fully connected. All tracking is GDPR-compliant and requires explicit cookie consent.
Disclaimer
CancerPath Intelligence presents cancer screening coverage data sourced from UKHSA Fingertips (PHE public health indicators) and ONS Open Geography. It is intended to support population health planning and commissioning decisions by NHS, Public Health, and Cancer Alliance stakeholders. This dashboard does not provide clinical diagnosis or replace NHS clinical systems. Data reflects aggregate population-level screening uptake and does not identify individual users. Figures should be interpreted alongside local clinical intelligence and public health context.